Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 218

1.

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.

Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, De Grandi P.

J Natl Cancer Inst. 2003 Aug 6;95(15):1128-37.

PMID:
12902442
2.

Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions.

Balmelli C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D.

J Virol. 1998 Oct;72(10):8220-9.

3.

Re: Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.

Barr E, Koutsky LA.

J Natl Cancer Inst. 2004 Mar 3;96(5):412-3; author reply 413-4. No abstract available.

PMID:
14996866
4.

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.

Nardelli-Haefliger D, Lurati F, Wirthner D, Spertini F, Schiller JT, Lowy DR, Ponci F, De Grandi P.

Vaccine. 2005 May 25;23(28):3634-41.

PMID:
15882523
5.

Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial.

Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, Alvarez FB, Bautista OM, Jansen KU, Barr E.

Obstet Gynecol. 2006 Jan;107(1):18-27. Erratum in: Obstet Gynecol. 2006 Jun;107(6):1425.

PMID:
16394035
6.

Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.

Nardelli-Haefliger D, Roden RB, Benyacoub J, Sahli R, Kraehenbuhl JP, Schiller JT, Lachat P, Potts A, De Grandi P.

Infect Immun. 1997 Aug;65(8):3328-36.

7.
8.

Characterization of IgA response among women with incident HPV 16 infection.

Onda T, Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA.

Virology. 2003 Jul 20;312(1):213-21.

9.

IgG and IgA content of vaginal fluid during the menstrual cycle.

Usala SJ, Usala FO, Haciski R, Holt JA, Schumacher GF.

J Reprod Med. 1989 Apr;34(4):292-4.

PMID:
2715991
10.

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.

Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR.

J Immunol. 2002 Jul 1;169(1):566-74.

12.

Rectal immunization for induction of specific antibody in the genital tract of women.

Crowley-Nowick PA, Bell MC, Brockwell R, Edwards RP, Chen S, Partridge EE, Mestecky J.

J Clin Immunol. 1997 Sep;17(5):370-9.

PMID:
9327336
13.

Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.

Revaz V, Zurbriggen R, Moser C, Schiller JT, Ponci F, Bobst M, Nardelli-Haefliger D.

Antiviral Res. 2007 Oct;76(1):75-85. Epub 2007 Jun 19.

PMID:
17617476
14.

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine.

Schwarz TF, Kocken M, Petäjä T, Einstein MH, Spaczynski M, Louwers JA, Pedersen C, Levin M, Zahaf T, Poncelet S, Hardt K, Descamps D, Dubin G.

Hum Vaccin. 2010 Dec;6(12):1054-61. Epub 2010 Dec 1.

PMID:
21157180
15.

Seric and local antibodies against a synthetic peptide of HPV16.

Dreyfus M, Baldauf JJ, Ritter J, Obert G.

Eur J Obstet Gynecol Reprod Biol. 1995 Apr;59(2):187-91.

PMID:
7657014
16.

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

Rose RC, Lane C, Wilson S, Suzich JA, Rybicki E, Williamson AL.

Vaccine. 1999 Apr 23;17(17):2129-35.

PMID:
10367945
17.
18.
19.

Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.

Bryan JT, Jansen KU, Lowe RS, Fife KH, McClowry T, Glass D, Brown DR.

J Med Virol. 1997 Nov;53(3):185-8.

PMID:
9365880
20.

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

Pastrana DV, Vass WC, Lowy DR, Schiller JT.

Virology. 2001 Jan 5;279(1):361-9.

Supplemental Content

Support Center